Article Details

Investors Purchase High Volume of Halozyme Therapeutics Put Options (NASDAQ:HALO)

Retrieved on: 2021-04-28 13:41:15

Tags for this article:

Click the tags to see associated articles and topics

Investors Purchase High Volume of Halozyme Therapeutics Put Options (NASDAQ:HALO). View article details on hiswai:

Excerpt

BlackRock Inc. now owns 18,481,307 shares of the biopharmaceutical company's stock worth $789,337,000 after purchasing an additional 5,272,072 ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up